Skip to main content

Other Clinical Liver Research Studies

Investigators

4910-Chalasani, Naga

Naga P. Chalasani, MD

Interim Chair, Department of Medicine

Read Bio

4795-Liangpunsakul, Suthat

Suthat Liangpunsakul, MD

Professor of Medicine

Read Bio

5166-Orman, Eric

Eric Orman, MD

Assistant Professor of Medicine

Read Bio

4796-Lammert, Craig

Craig Lammert, MD

Assistant Professor of Medicine

Read Bio

38486-Nephew, Lauren

Lauren D. Nephew, MD

Assistant Professor of Medicine

Read Bio

5034-Vuppalanchi, Raj

Raj Vuppalanchi, MB,BS

Professor of Medicine

Read Bio

Arrowhead

Enrolling: Yes

Principle Investigator: Raj Vuppalanchi, MD

Duration: Upwards of 2 years

Patient Population: F2 - 3

Drug(s): ARO-AAT

Interested in this study? Please contact the following coordinator:
Holly King
hrking1@iu.edu
(317) 278-6200

Fibroscan Database

Enrolling: Yes

Principle Investigator: Naga Chalasani, MD

Duration: 1 visit

Interested in this study? Please contact the following coordinator:
Regina Weber
reginaw@iu.edu
(317) 278-3584

Hepatic Adenoma Biorepository

Enrolling: Yes

Principle Investigator: Craig Lammert, MD

Duration: 1 visit

Patient Population: Hepatic adenoma with history of oral contraceptive use.

Interested in this study? Please contact the following coordinator:
Kelsey Green
greenke@iu.edu
(317) 278-9292

Liver Biopsy Collection

Enrolling: Yes

Principle Investigator: Naga Chalasani, MD

Duration: 1 visit

Patient Population: Patients receiving liver biopsies excluding those with viral hepatitis and alcoholic liver disease.

Interested in this study? Please contact the following coordinators:
Nan Ash

na1@iu.edu

(317) 278-6201


Jake McCarty
jacmccar@iu.edu
(317) 278-6305

 

Brandon Wind

bewind@iu.edu

(317) 278-6222

Palliative Care Within ESLD

Enrolling: Yes

Principle Investigator: Eric Orman, MD

Duration: 1 year, 7 visits required, but 4 can be completed over the phone.

Patient Population: Adults over 18 years old with new onset or ongoing complications of End Stage Liver Disease (ESLD) including Hepatocellular Cancer (HCC), with a caregiver willing to participate.

Interested in this study? Please contact the following coordinator:

Nicole Garcia

garcini@iu.edu

(317) 278-0411

Post Liver Transplant Quality of Life Sub-Study

Enrolling: Yes

Principle Investigator: Naga Chalasani, MD

Duration: 1 visit

Patient Population: Patients that are over 18 years old that have had a liver transplant.

Interested in this study? Please contact the following coordinator:
Logan Hobbs
lshobbs@iu.edu
(317) 274-8422

TREAT - 005

Enrolling: Yes

Principle Investigator: Suthat Liangpunsakul, MD

Duration: 42 days

Patient Population: Adults 21-65 years old, healthy controls with no alcohol use or heavy alcohol drinkers without liver disease.

Interested in this study? Please contact the following coordinator:
Jennifer Lehman
jgeck@iu.edu
(317) 278-1872

View the study on clinicaltrials.gov

Understanding Racial Disparities in Curative Therapies for Hepatocellular Carcinoma: A Prospective Cohort Study

Enrolling: Yes

Principle Investigator: Lauren Nephew, MD

Duration: 1 year.

Patient Population: Patients over 18 years old with the diagnosis of Hepatocellular Cancer (HCC) within one year.

Interested in this study? Please contact the following coordinator:

Nicole Garcia

garcini@iu.edu

(317) 278-0411

Closed Studies

  • Cystic Fibrosis Study

    Enrolling: No

    Principle Investigator: Naga Chalasani, MD

    Duration: 1 visit

    Patient Population: Aged 18 or greater with a diagnosis of cystic fibrosis.